Determination of the in-tumor-concentration of imatinib mesylate in malignant glioma after oral administration
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Imatinib (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
- Focus Pharmacokinetics
- 17 Nov 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 17 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Dec 2006 New trial record.